Adenomyoepithelioma of the breast: a proposal for classification

E Rakha, PH Tan, I Ellis, C Quinn - Histopathology, 2021 - Wiley Online Library
Breast lesions with a prominent myoepithelial cell component constitute a heterogeneous
group of benign and malignant neoplastic proliferations. These lesions are often dual …

Salivary mucinous adenocarcinoma is a histologically diverse single entity with recurrent AKT1 E17K mutations: clinicopathologic and molecular characterization with …

LM Rooper, PP Argyris, LDR Thompson… - The American Journal …, 2021 - journals.lww.com
Mucin-producing salivary adenocarcinomas were historically divided into separate colloid
carcinoma, papillary cystadenocarcinoma, and signet ring cell carcinoma diagnoses based …

[HTML][HTML] Mutational signatures in salivary gland carcinomas

A Chrysovergis, V Papanikolaou… - Cancer Diagnosis & …, 2023 - ncbi.nlm.nih.gov
Salivary gland carcinomas belong to the head and neck carcinoma super category of
malignancies. They are characterized by histopathological diversity and comprise a variety …

The diagnostic utility of RAS Q61R mutation-specific immunohistochemistry in epithelial-myoepithelial carcinoma

M Nakaguro, M Tanigawa, H Hirai… - The American journal …, 2021 - journals.lww.com
Epithelial-myoepithelial carcinoma (EMC) is a rare salivary gland cancer characterized by
biphasic tubular structures composed of inner ductal and outer clear myoepithelial cells …

Recurrent IDH2 mutations in salivary gland striated duct adenoma define an expanded histologic spectrum distinct from canalicular adenoma

LM Rooper, A Agaimy, A Assaad, M Bal… - The American Journal …, 2023 - journals.lww.com
Striated duct adenoma (SDA) is a rare salivary gland neoplasm defined by histologic
similarity to normal striated ducts. However, doubt persists about whether SDA represents a …

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast

I Bièche, F Coussy, R El-Botty, S Vacher… - Journal of Hematology & …, 2021 - Springer
Malignant adenomyoepithelioma (AME) of the breast is an exceptionally rare form of breast
cancer, with a significant metastatic potential. Chemotherapy has been used in the …

Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity

PS Ginter, PJ McIntire, B Kurtis, S Mirabelli… - Modern …, 2020 - nature.com
Adenomyoepitheliomas (AMEs) of the breast are uncommon and span the morphologic
spectrum of benign, atypical, in situ, and invasive forms. In exceptionally rare cases, these …

Salivary Gland–like Tumors of the Breast: A Comparison of Clinicopathologic Features and Molecular Pathogenesis with Their Salivary Gland Counterparts

ET Richardson, VY Jo… - Archives of Pathology & …, 2023 - meridian.allenpress.com
Context The World Health Organization classification of tumors of the breast recognizes
several special type carcinomas and benign lesions with features comparable to those of …

Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast

XR Luo, JT She, T Xu, Y Zhou, CB Xu, JP Jiang… - …, 2021 - Taylor & Francis
Adenomyoepithelioma (AME) of the breast is a rare tumor that is composed of proliferating
epithelial and myoepithelial cells. The pathogenesis of AME remains unclear, and no breast …

Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma

K Kawachi, X Tang, R Kasajima, T Yamanaka… - Breast Cancer Research …, 2023 - Springer
Purpose Low-grade adenosquamous carcinoma (LGASC) is a rare type of metaplastic
carcinoma of the breast (MBC) with an indolent clinical course. A few LGASC cases with …